EA202191632A1 - Ахромосомные динамические активные системы - Google Patents

Ахромосомные динамические активные системы

Info

Publication number
EA202191632A1
EA202191632A1 EA202191632A EA202191632A EA202191632A1 EA 202191632 A1 EA202191632 A1 EA 202191632A1 EA 202191632 A EA202191632 A EA 202191632A EA 202191632 A EA202191632 A EA 202191632A EA 202191632 A1 EA202191632 A1 EA 202191632A1
Authority
EA
Eurasian Patent Office
Prior art keywords
achromosomal
adas
active systems
dynamic active
present
Prior art date
Application number
EA202191632A
Other languages
English (en)
Inventor
Адам Барклей Фишер
Кимберли А. Хоман
Трой Патрик Хаббард
Дэвид Барри Колески
Анализ Заунбрехер Ривз
Кейтлин Николь Сполдинг
Хок Хеи Там
Original Assignee
ФЛЭГШИП ПАЙОНИРИНГ ИННОВЕЙШНЗ VI, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ФЛЭГШИП ПАЙОНИРИНГ ИННОВЕЙШНЗ VI, ЭлЭлСи filed Critical ФЛЭГШИП ПАЙОНИРИНГ ИННОВЕЙШНЗ VI, ЭлЭлСи
Publication of EA202191632A1 publication Critical patent/EA202191632A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В настоящем изобретении предусмотрены выделенные ахромосомные динамические активные системы (ADAS), включая высокоактивные ADAS. Эти ADAS, предусмотренные в настоящем изобретении, могут быть получены посредством различных способов. Предусмотрены различные связанные способы получения и применения этих ADAS.
EA202191632A 2018-12-10 2019-12-10 Ахромосомные динамические активные системы EA202191632A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862777305P 2018-12-10 2018-12-10
PCT/US2019/065562 WO2020123569A1 (en) 2018-12-10 2019-12-10 Achromosomal dynamic active systems

Publications (1)

Publication Number Publication Date
EA202191632A1 true EA202191632A1 (ru) 2021-12-06

Family

ID=71077548

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191632A EA202191632A1 (ru) 2018-12-10 2019-12-10 Ахромосомные динамические активные системы

Country Status (15)

Country Link
US (1) US20220031862A1 (ru)
EP (1) EP3893856A4 (ru)
JP (1) JP2022513709A (ru)
KR (1) KR20210101260A (ru)
CN (1) CN113498338A (ru)
AU (1) AU2019397460A1 (ru)
BR (1) BR112021011044A2 (ru)
CA (1) CA3121520A1 (ru)
CL (2) CL2021001466A1 (ru)
CO (1) CO2021008980A2 (ru)
EA (1) EA202191632A1 (ru)
IL (1) IL283510A (ru)
MX (1) MX2021006564A (ru)
SG (1) SG11202105822WA (ru)
WO (1) WO2020123569A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018201160A1 (en) 2017-04-28 2018-11-01 Agrospheres, Inc. Compositions and methods for enzyme immobilization
US11649265B2 (en) 2017-04-28 2023-05-16 Agrospheres, Inc. Compositions and methods for the encapsulation and scalable delivery of agrochemicals
CA3073449A1 (en) 2017-09-25 2019-03-28 Agrospheres, Inc. Compositions and methods for scalable production and delivery of biologicals
AU2021292539A1 (en) * 2020-06-17 2023-02-02 Flagship Pioneering Innovations Vi, Llc ADAS comprising bacterial secretion systems
EP4168025A1 (en) * 2020-06-17 2023-04-26 Flagship Pioneering Innovations VI, LLC Methods for manufacturing adas
CN112342233B (zh) * 2020-11-10 2022-08-26 上海陶宇晟生物技术有限责任公司 用于细菌表达DacA时提高c-di-AMP产量的多核苷酸
WO2023164454A2 (en) * 2022-02-22 2023-08-31 Board Of Regents For The Oklahoma Agricultural And Mechanical Colleges Compositions and methods for improved rhizobium-mediated plant transformation
WO2023250487A1 (en) 2022-06-23 2023-12-28 Flagship Pioneering Innovations Vi, Llc Adas comprising type 1 pili
CN115851800A (zh) * 2022-09-20 2023-03-28 天津大学 一种提高希瓦氏菌电子传递能力的方法
WO2024107853A1 (en) 2022-11-15 2024-05-23 Flagship Pioneering Innovations Vi, Llc Optimized achromosomal dynamic active systems and uses thereof
WO2024107843A1 (en) 2022-11-15 2024-05-23 Flagship Pioneering Innovations Vi, Llc Stabilized achromosomal dynamic active systems and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
LT2351772T (lt) * 2005-02-18 2016-10-10 Glaxosmithkline Biologicals Sa Baltymai ir nukleorūgštys iš su meningitu/sepsiu susijusių escherichia coli
US9844598B2 (en) * 2011-12-13 2017-12-19 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
US9951340B2 (en) * 2013-03-07 2018-04-24 The General Hospital Corporation Compositions and methods for bacterial delivery of polypeptides
US11649265B2 (en) * 2017-04-28 2023-05-16 Agrospheres, Inc. Compositions and methods for the encapsulation and scalable delivery of agrochemicals

Also Published As

Publication number Publication date
CL2023001550A1 (es) 2023-11-03
BR112021011044A2 (pt) 2021-08-31
JP2022513709A (ja) 2022-02-09
CN113498338A (zh) 2021-10-12
AU2019397460A1 (en) 2021-06-17
WO2020123569A1 (en) 2020-06-18
KR20210101260A (ko) 2021-08-18
CA3121520A1 (en) 2020-06-18
EP3893856A1 (en) 2021-10-20
MX2021006564A (es) 2021-08-11
EP3893856A4 (en) 2022-10-05
US20220031862A1 (en) 2022-02-03
IL283510A (en) 2021-07-29
CO2021008980A2 (es) 2021-07-30
SG11202105822WA (en) 2021-06-29
CL2021001466A1 (es) 2021-11-26

Similar Documents

Publication Publication Date Title
EA202191632A1 (ru) Ахромосомные динамические активные системы
CL2020000596S1 (es) Auriculares.
AR114687A1 (es) Pares citoquinas / receptores ortogonales biológicamente relevantes
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
BR112019012342A2 (pt) anticorpos il-11
EA201790545A1 (ru) Антитела и иммуноконъюгаты против her2
MX2019007021A (es) Anticuerpos il-11ra.
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
TR2021016542A2 (tr) Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.
EA201690617A1 (ru) Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
MX2018010971A (es) Compuestos y métodos para modular la tirosina cinasa de bruton.
PH12020551716A1 (en) Anti-ror antibody constructs
EA201992409A1 (ru) Ингибиторы magl на основе пиразола
EA202091989A1 (ru) Способы лечения язвенного колита
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
CO2022004797A2 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5/klk7 y métodos de uso
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA202190633A1 (ru) Лекарственные формы для применения в педиатрии, способы получения и применения
PH12021550289A1 (en) Ox40-binding polypeptides and uses thereof
TR201901228T4 (tr) Vortioksetin piroglutamat.
BR112018072699A2 (pt) determinados inibidores de proteína cinase
EA201892376A1 (ru) Комбинированный состав трех противовирусных соединений
EA201500941A1 (ru) Способы и композиции для модуляции гамма-глутамилового цикла